1 ition that was recently confirmed in a major
pooled analysis.
2 e was no between-trial heterogeneity for any
pooled analysis.
3 BDES and BMES at validation, and 0.87 in the
pooled analysis.
4 n improved specificity from 61 to 78% in the
pooled analysis.
5 to body mass index (BMI) groups, in a large
pooled analysis.
6 2, and 55.4% versus 46.7% (P = 0.003) in the
pooled analysis.
7 from the ASCEND trial) were included in the
pooled analysis.
8 A total of 479 patients were included in the
pooled analysis.
9 pulations was tested via chi2 tests before a
pooled analysis.
10 erved for Asians, Latinos, and blacks in the
pooled analysis.
11 rs for non-Hodgkin lymphoma (NHL) in a large
pooled analysis.
12 27% and 23%, respectively, and by 25% in the
pooled analysis.
13 n 1,362 eligible patients for inclusion in a
pooled analysis.
14 set, and verified in the validation set and
pooled analysis.
15 t sonidegib, had enough studies to warrant a
pooled analysis.
16 us, and tumor histology, is validated by our
pooled analysis.
17 n total, 2,038 patients were included in the
pooled analysis.
18 Significance level was set at .01 for
pooled analysis.
19 In the
pooled analysis (
1,038 cases and 877 controls with genot
20 ime, 285 minutes) contributed to the present
pooled analysis (
120 with internal carotid artery occlus
21 tudies; 11,936 cases, 18,714 controls) and a
pooled analysis (
14 studies; 5,068 cases, 7,876 controls
22 In this
pooled analysis,
2,282 patients underwent both IGRA and
23 In the
pooled analysis,
390 (96%) of 406 adults and 133 (95%) o
24 In a
pooled analysis,
4 of the 12 risk variants were strongly
25 In the
pooled analysis,
525 of 659 patients (79.7%) in the dalb
26 In a
pooled analysis,
563 patients received tolevamer, 289 re
27 The
pooled analysis also revealed that maternal overweight o
28 Pooled analysis also showed significant improvements in
29 he dosing interval, 157 ng/mL (28.6-1360) in
pooled analysis and 315 ng/mL (108-1360) in CYP2B6 516TT
30 d summary risk estimates across cohorts with
pooled analysis and random-effects meta-analysis methods
31 ysis is highly consistent with rectal cancer
pooled analysis and SEER rectal cancer analyses, support
32 Estimated PSA control rates in this
pooled analysis are similar to those of single instituti
33 s, and significantly lower (P < 0.05) in the
pooled analysis,
as was plasma glutamine.
34 The authors carried out a
pooled analysis based on primary data (1960-2001) from 1
35 We performed a
pooled analysis,
based on the intention to treat, of ind
36 nd for 4018 controls, and were assessed in a
pooled analysis by use of a random-effects logistic regr
37 f MI in relation to use of low-dose OCs in a
pooled analysis combining results from the 2 sites.
38 In a
pooled analysis comprising 9,533 cases and 11,389 contro
39 In the
pooled analysis,
consumption of >/=10 mg isoflavones/d w
40 Our
pooled analysis could not validate pathological complete
41 In this
pooled analysis,
CT significantly improved PFS1, PFS2, a
42 with rectal cancer were compared with rectal
pooled analysis data (3,791 patients).
43 The results of this
pooled analysis demonstrate that sertraline is an effect
44 Treatment with daclizumab in the
pooled analysis demonstrated a significant reduction in
45 This
pooled analysis demonstrated no gender difference in pro
46 Our
pooled analysis demonstrated that African American ethni
47 In conclusion, this large
pooled analysis did not support an overall association b
48 In the
pooled analysis,
exercise training was associated with s
49 Consequently, few opportunities for
pooled analysis exist.
50 with oral glycoprotein IIb/IIIa inhibition,
pooled analysis favored an increase in myocardial infarc
51 eks, we noted significant differences in the
pooled analysis favouring pirfenidone therapy compared w
52 risk ratio favoring drug over placebo in the
pooled analysis for FM30 version 3 (short version) was 1
53 Favorable associations were found in the
pooled analysis for intakes of vitamins E and B(6) and f
54 In the present large-scale
pooled analysis from 2 multicenter randomized trials, ea
55 In a patient-level
pooled analysis from 4 all-comers trials, 6081 patients
56 We performed a patient-level
pooled analysis from 4 randomized SES versus BMS trials
57 e 95 lipid-associated loci were novel to the
pooled analysis from over 100 000 individuals.
58 Based on a
pooled analysis from the 3 phase 3 CHAMPION trials, cang
59 In a patient-level
pooled analysis from the Harmonizing Outcomes With Revas
60 In
pooled analysis,
Gutt et al.'s insulin sensitivity index
61 a modest increase in overall mortality in a
pooled analysis (
hazard ratio [HR] comparing extreme dec
62 io, 1.17; CI, 1.00-1.36; P=0.045) and in the
pooled analysis (
hazard ratio, 1.12; CI, 1.00-1.24; P=0.
63 In the
pooled analysis,
higher circulating 25(OH)D(3) concentra
64 Classical approaches for meta-analysis or
pooled analysis,
however, might not be suitable for such
65 We did a
pooled analysis in the intention-to-treat population usi
66 m baseline to year 3 were not significant in
pooled analysis in the second eyes or the previously inj
67 The
pooled analysis included 1,699 cases and 2,422 controls
68 This
pooled analysis included data from 67 phase I to IV clin
69 This
pooled analysis includes 1 of the largest patient-level
70 However, in a prespecified
pooled analysis incorporating results from two previous
71 The results of
pooled analysis indicated that none of the six investiga
72 Pooled analysis indicated that only G12A was associated
73 Pooled analysis involving children 1 week to 59 months o
74 distinguished all three mutagens and in the
pooled analysis IR was associated with mutational signat
75 In this large
pooled analysis,
late age at last birth was independentl
76 In a
pooled analysis,
low-frequency HIV-1 drug resistance mut
77 In the
pooled analysis,
maternal smoking only during pregnancy
78 In the
pooled analysis,
median time from discontinuation as a r
79 Consistent with the
pooled analysis,
meta-analyses for all-cause mortality a
80 In the
pooled analysis (
n = 11,635), the RR of death was reduce
81 ed disorders (ICD F20-29) were included in a
pooled analysis (
N = 1396).
82 In a
pooled analysis (
n = 59), we observed a significant diff
83 global policy, a detailed meta-analysis and
pooled analysis needs to be undertaken using data from b
84 In this
pooled analysis no association was observed between omal
85 s in both subpopulations separately and in a
pooled analysis (
odds ratio 0.54, 95% CI 0.39-0.75, p<0.
86 We conducted a
pooled analysis of 10 211 NHL cases and 11 905 controls
87 ctive studies, 35 case-control studies and 1
pooled analysis of 10 cohort and 14 case-control studies
88 In a retrospective
pooled analysis of 11 clinical trials of lenalidomide-ba
89 This study represents a patient-level
pooled analysis of 12 459 patients recruited in 6 random
90 e in relation to pancreatic cancer risk in a
pooled analysis of 14 prospective studies from North Ame
91 Here, we present an updated
pooled analysis of 148 patients treated with daratumumab
92 We investigated these associations in a
pooled analysis of 18 cohort studies.
93 Pooled analysis of 2 multicenter, randomized clinical tr
94 This was a
pooled analysis of 2 prospective studies including 61,64
95 treatment imposed by CD49d was estimated by
pooled analysis of 2,972 CLLs; Cox analysis stratified b
96 In a
pooled analysis of 20 prospective studies from the Unite
97 put variables for ELHR were estimated from a
pooled analysis of 20 published studies, while those for
98 rrence and death across all time points in a
pooled analysis of 20,898 patients with colon cancer fro
99 q24 regions associated with cancer risk in a
pooled analysis of 2587 colorectal adenoma cases, 547 co
100 DESIGN, SETTING, AND PARTICIPANTS: A
pooled analysis of 26 observational studies on the survi
101 nts that occur at SBP/DBP <140/90 mm Hg in a
pooled analysis of 3 contemporary US cohorts: the REGARD
102 was investigated in a prospectively defined
pooled analysis of 3 large, placebo-controlled, randomiz
103 Pooled analysis of 3 studies found higher odds of AD in
104 For generalized anxiety disorder, a
pooled analysis of 3 trials showed that quetiapine was a
105 A retrospective, multi-institutional
pooled analysis of 3,162 men undergoing RP was conducted
106 A
pooled analysis of 37,568 patients in 25 randomized tria
107 umab (AMG 145) on lipoprotein (Lp)(a) from a
pooled analysis of 4 phase II trials.
108 In a
pooled analysis of 4 randomized trials, 1,748 patients w
109 We performed a patient-level
pooled analysis of 4 randomized, placebo-controlled tria
110 Pooled analysis of 4 studies found higher odds of AD in
111 Pooled analysis of 4 trials resulted in a statistically
112 In a
pooled analysis of 4 US epidemiologic studies (1993-2001
113 We conducted an individual-based
pooled analysis of 45 twin cohorts from 20 countries, in
114 A
pooled analysis of 5 international (Australia, New Zeala
115 DESIGN, SETTING, AND PARTICIPANTS:
Pooled analysis of 5 longitudinal cohort studies: Athero
116 This was a
pooled analysis of 515 eyes from 360 patients 18 to 49 y
117 In a
pooled analysis of 6 birth cohorts (Ntotal = 15,299), we
118 We performed a
pooled analysis of 6 population-based studies within the
119 The study was a
pooled analysis of 6,186 patients who underwent coronary
120 In a collaborative
pooled analysis of 7 endovascular databases, we assessed
121 We conducted a
pooled analysis of 7 nested case-control studies in the
122 In a
pooled analysis of 8,692 NHL cases and 9,260 controls fr
123 We conducted a
pooled analysis of 869 individual newly diagnosed elderl
124 DESIGN, SETTING, AND PARTICIPANTS:
Pooled analysis of 9 cohort studies (collected between 1
125 A
pooled analysis of 9 studies reporting mortality reveale
126 dies of six distinct cancers and another for
pooled analysis of a case-control study of glioma, a cla
127 METHODS AND This is a
pooled analysis of ACRIN-PA (American College of Radiolo
128 We performed a patient-level
pooled analysis of adjudicated data from 7950 patients i
129 In a
pooled analysis of all 19 studies, children with eczema
130 Pooled analysis of all sites found significant associati
131 In the second part, we performed a
pooled analysis of all studies published between 1976 an
132 In the
pooled analysis of ASCOT, ELSA, and NPHSII, there was no
133 15% lower risk of T2D, respectively, in the
pooled analysis of both cohorts.
134 A
pooled analysis of both studies yielded an estimate of t
135 , and New Zealand between 1985 and 2010 (the
Pooled Analysis of Case-Control Studies on the Joint Eff
136 The authors present a meta- and a
pooled analysis of case-control studies that examined th
137 Pooled analysis of CD40 cross-linking of AdVMART1/DC adm
138 A recent
pooled analysis of clinical trials showed that nuts are
139 According to a
pooled analysis of controlled clinical trials with warfa
140 infections in endemic populations based on a
pooled analysis of cross-sectional data.
141 A
pooled analysis of data from 1,359 patients in 4 phase I
142 We performed a
pooled analysis of data from 1594 patients with CD who p
143 gregation of glioma, the authors performed a
pooled analysis of data from 2 large glioma case-control
144 In a
pooled analysis of data from 5 statin trials, intensive-
145 , we report here an individual patient-level
pooled analysis of data from five trials comparing anthr
146 We performed a
pooled analysis of data from four double-blind trials in
147 Based on a
pooled analysis of data from individual patients with PL
148 In a
pooled analysis of data from South and East Asian countr
149 We designed a prespecified
pooled analysis of data from three trials in which patie
150 We did a
pooled analysis of data from three trials that assessed
151 lure in the elderly, the authors conducted a
pooled analysis of data from two case-control studies of
152 We therefore did a
pooled analysis of data to investigate the association b
153 Pooled analysis of EDIPS trial data reinforces evidence
154 n of the largest European trial, NELSON, and
pooled analysis of European CT screening trials, we disc
155 r GOLD 2007 and 2011, we did a patient-based
pooled analysis of existing data.
156 For 8 of these 11 associations,
pooled analysis of follow-up studies yielded statistical
157 We conducted a
pooled analysis of four birth cohorts (children's center
158 We conducted a
pooled analysis of HL risk focusing on type and timing o
159 Finally, a
pooled analysis of in-house and published datasets was c
160 In this
pooled analysis of individual data from 9 selected cohor
161 The authors performed the first
pooled analysis of individual participant data from comp
162 We performed a
pooled analysis of individual participant data using all
163 th dose-response meta-analysis and, finally,
pooled analysis of individual participant data, add insi
164 We did a systematic review and
pooled analysis of individual patient data from 8382 par
165 th metastatic breast cancer by undertaking a
pooled analysis of individual patient data.
166 In this light, we performed a collaborative
pooled analysis of individual-level data from all 11 pub
167 We did a
pooled analysis of individual-level data from nationally
168 We performed a
pooled analysis of long-term outcomes in patients with M
169 In the
pooled analysis of MAGI2, two large deletions were found
170 The authors conducted a
pooled analysis of meningioma risk in relation to a hist
171 In a
pooled analysis of more than 31,000 women of East-Asian,
172 These findings illustrate the utility of
pooled analysis of mouse and human sequencing data.
173 This
pooled analysis of multicenter, prospective RTOG bladder
174 We did a
pooled analysis of new, harmonised, individual-level ana
175 We conducted a
pooled analysis of one-year mortality data on ART accoun
176 his prospectively planned individual-patient
pooled analysis of patient cases from five adjuvant tria
177 velopment of clinical events, we conducted a
pooled analysis of patient-level data from the 10 random
178 This prespecified,
pooled analysis of patient-level data from three trials
179 rge, randomized, placebo-controlled trial, a
pooled analysis of patient-level data, or both may resol
180 Similarly,
pooled analysis of pediatric and adult cohorts indicated
181 ifference in specificity was detected in the
pooled analysis of PET and SPECT MPI.
182 ased risk of type 1 diabetes by performing a
pooled analysis of previous studies using individual pat
183 nce of Electrical Storm) is a patient-level,
pooled analysis of previously published data sets.
184 ident, sporadic colorectal adenoma risk in a
pooled analysis of primary data from 3 colonoscopy-based
185 Pooled analysis of prospective cohort studies and random
186 Retrospective
pooled analysis of prospectively collected data.
187 We did a
pooled analysis of published and unpublished individual-
188 We did a
pooled analysis of published national data from Sweden,
189 We compared outcomes to
pooled analysis of published studies in solid tumors wit
190 In 2007, a
pooled analysis of randomised trials in Europe demonstra
191 Conclusion This large, prospective,
pooled analysis of randomized chemotherapy, immunotherap
192 Pooled analysis of randomized controlled trials of intra
193 In a
pooled analysis of randomized trial data, use of statin
194 In a
pooled analysis of randomized trials in unfavorable-risk
195 Methods We reviewed
pooled analysis of rare end points across cohorts, regar
196 Data from a
pooled analysis of risk factors indicate that the higher
197 ersus G/G (P for trend 2.0 x 10(-15)) in the
pooled analysis of samples from all three stages.
198 In a
pooled analysis of short-term trials, short-term treatme
199 ment of lung cancer, the authors conducted a
pooled analysis of studies in the International Lung Can
200 was no significant difference in risk in the
pooled analysis of studies that compared rainwater to im
201 In a
pooled analysis of surveys that measured malaria, stunti
202 Compared with baseline,
pooled analysis of ten participants showed improvements
203 Pooled analysis of the 26 unique studies demonstrated a
204 Pooled analysis of the 3 asthma-ascertained samples show
205 A
pooled analysis of the 5 trials completed by early 2005
206 Pooled analysis of the 6 prospective studies indicated t
207 Pooled analysis of the 7 cross-sectional studies suggest
208 The objective of this study was to conduct a
pooled analysis of the associations of the concentration
209 We did a
pooled analysis of the combined patient populations of t
210 s developed to conduct an individual patient
pooled analysis of the data from these published clinica
211 risk of incident diabetes (P = 0.001) in the
pooled analysis of the discovery cohort together with th
212 nalysis of summarized published data and the
pooled analysis of the individual original data were sma
213 We performed a
pooled analysis of the interaction between HLA-DRB1 and
214 cause mortality a secondary end point in the
pooled analysis of the low LVEF trials.
215 Pooled analysis of the NHS and WHS cohorts demonstrated
216 Pooled analysis of the paediatric and adult cohorts indi
217 Pooled analysis of the relation between rs33972313 and c
218 This study is a
pooled analysis of the results from the randomised, doub
219 A preplanned
pooled analysis of the results of this study with those
220 A
pooled analysis of the RIBS IV (Restenosis Intra-Stent o
221 This patient-level
pooled analysis of the RIBS IV and RIBS V randomized cli
222 In the
pooled analysis of the studies that included control pat
223 In a
pooled analysis of the three cohorts, psoriatics younger
224 In the
pooled analysis of the three trials, 604 patients were r
225 We report updated results, including a
pooled analysis of the two studies.
226 In a
pooled analysis of the two trials involving the face and
227 In a
pooled analysis of the two trials involving the trunk an
228 Pooled analysis of these secondary prevention trials (n
229 In the
pooled analysis of these two trials, docetaxel did not h
230 Pooled analysis of this study RE-COVER II and the RE-COV
231 In a
pooled analysis of three phase III IPF clinical trials,
232 es' Health Study (NHS), and then conducted a
pooled analysis of three studies.
233 fited from anticoagulation, 49% according to
pooled analysis of trial results, and 41% according to t
234 In this
pooled analysis of two cohorts from the phase 1 dose-exp
235 We conducted a joint (
pooled) analysis of three genome-wide association studie
236 ata from multiple studies for the purpose of
pooled analysis or meta-analysis, and will probably prov
237 In this patient-level
pooled analysis,
overall use of SES compared with BMS de
238 ases and 569 controls, P = 7.1e-03) and in a
pooled analysis (
P = 1.8e-04), with an over-representati
239 ok1 f alleles and ovarian cancer risk in the
pooled analysis (
P(trend) = 0.03).
240 In a
pooled analysis,
participants with both the Hp2-2 genoty
241 ternational Lymphoma Epidemiology Consortium
pooled analysis,
polymorphisms in 2 immune-system-relate
242 In a
pooled analysis,
prebronchodilator FEV(1) increased by 4
243 This large
pooled analysis provided sufficient numbers of related f
244 27% reduction in nonvertebral fractures in a
pooled analysis (
reduction favoring HRT in relative risk
245 The findings of this large
pooled analysis reinforce the hypothesis that day-care c
246 Pooled analysis resulted in a crude OR of 1.25 (95% CI:
247 A
pooled analysis revealed that the elimination of daily r
248 Pooled analysis revealed that there was a significant in
249 In the
pooled analysis,
seven additional insertions or deletion
250 The
pooled analysis showed an overall significant weight red
251 Pooled analysis showed nonsignificantly lower maternal v
252 Pooled analysis showed that in women age >/= 50 years, s
253 Overall, the
pooled analysis showed that mir-196a2 rs11614913 was ass
254 Compared with the lowest category, the
pooled analysis showed that the highest Mediterranean di
255 In the
pooled analysis,
significantly fewer moderate and severe
256 In
pooled analysis,
statins were not associated with increa
257 The results of this
pooled analysis suggest that the two endometrial cancer
258 ing 1854 patients with NICM were identified;
pooled analysis suggested a significant reduction in tot
259 observed between NSAID use and EAC risk, our
pooled analysis suggests a possible role for NSAIDs in p
260 The evidence from a
pooled analysis suggests that statins improve survival i
261 The outcomes of this
pooled analysis support minimal volume standards in rect
262 For each end point, we performed
pooled analysis that compared the effects of UDCA with t
263 In the
pooled analysis,
the difference in weight change during
264 In a
pooled analysis,
the extended-release venlafaxine group
265 In the
pooled analysis,
the odds ratio for low-grade glioma ass
266 In the
pooled analysis,
the overall RR was 1.3 (95% CI, 1.1 to
267 In the
pooled analysis,
the primary end point of death, myocard
268 In the
pooled analysis,
the relative reduction in the risk of d
269 In the
pooled analysis,
there was a greater reduction in UPE in
270 In the
pooled analysis,
there was an overall association (odds
271 We performed a
pooled analysis to evaluate the relationship between NNR
272 We performed a
pooled analysis to investigate these associations.
273 Pooled analysis using a random-effects model demonstrate
274 ation for mass HCC screening, we conducted a
pooled analysis using data from three cohorts involving
275 Recent studies, including a
pooled analysis,
validate prior data demonstrating the p
276 The trials were analysed separately and a
pooled analysis was also done.
277 Pooled analysis was based on random effects models.
278 A
pooled analysis was conducted of NHS, ICARE, and the 1 p
279 A multicenter
pooled analysis was conducted with the use of individual
280 An individual-level prospective
pooled analysis was conducted.
281 Pooled analysis was done using a random-effects model, a
282 A
pooled analysis was performed and subgroup analysis was
283 A
pooled analysis was performed based on individual partic
284 A
pooled analysis was performed by using patient data and
285 A
pooled analysis was performed to identify factors associ
286 all identified studies were included, a new
pooled analysis was performed.
287 A patient-level
pooled analysis was undertaken in 3 federally-funded tri
288 Using a collaborative
pooled analysis,
we examined whether early mortality aft
289 For this
pooled analysis,
we searched all available studies and i
290 als (TRAFFIC and TRANSPORT) included in this
pooled analysis were multinational, randomised, double-b
291 Primary and secondary end points of
pooled analysis were overall survival and disease-free s
292 This
pooled analysis with a follow-up of more than 10 years c